Eruptive Epidermal Inclusion Cysts in a Renal Transplant Patient on Tacrolimus
Main Article Content
Keywords
epidermal inclusion cyst, EIC, tacrolimus, calcineurin inhibitor, transplant
Abstract
Epidermal inclusion cysts are common cutaneous lesions that can develop anywhere on the body. While benign, these cysts can become inflamed and symptomatic. Symptomatic epidermal inclusion cysts can be treated with intralesional steroid injections or antibiotics, but surgical excision is often necessary for definitive treatment. We present a unique case of tacrolimus-induced eruptive epidermal inclusion cysts on the head and trunk of an adult male post-renal transplantation. Physicians should be familiar with this potential adverse effect, especially due to the difficulty of obtaining definitive treatment for a multitude of epidermal inclusion cysts.
References
2. Bencini PL, Montagnino G, Sala F, De Vecchi A, Crosti C, Tarantino A. Cutaneous lesions in 67 cyclosporin-treated renal transplant recipients. Dermatologica. 1986;172(1):24-30. doi:10.1159/000249288
3. Tiwari V, Gupta A, Gothwal C, et al. Tacrolimus-induced Epidermoid Cysts in the Renal Transplant Patient. Indian J Nephrol. 2021;31(6):571-573. doi:10.4103/ijn.IJN_318_19
4. Ahn IS, Chung BY, Cho SI, Kim HO, Park CW, Lee CH. Epidermal cysts in a tacrolimus treated renal transplant recipient. Ann Dermatol. 2011;23(Suppl 2):S182-S184. doi:10.5021/ad.2011.23.S2.S182
5. Verma S, Batra R, Gupta S, Zouboulis CC. Epidermoid cysts in kidney transplant patients receiving tacrolimus. Dermatol Ther. 2020;33(2):e13259. doi:10.1111/dth.13259
6. Safarini OA, Keshavamurthy C, Patel P. Calcineurin Inhibitors. In: StatPearls. Treasure Island (FL): StatPearls Publishing; November 24, 2022.
7. Gupta S, Radotra BD, Kumar B, Pandhi R, Rai R. Multiple, large, polypoid infundibular (epidermoid) cysts in a cyclosporin-treated renal transplant recipient. Dermatology. 2000;201(1):78. doi:10.1159/000018441
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.